United States Inhalers Market Report 2016

United States Inhalers Market Report 2016

1 Inhalers Overview

1.1 Product Overview and Scope of Inhalers

1.2 Classification of Inhalers

1.2.1 Reliever inhalers

1.2.2 Preventer inhalers

1.2.3 Long-acting bronchodilator inhalers

1.3 Application of Inhalers

1.3.1 Metered dose inhalers (MDIs)

1.3.2 Dry powder (DPI)

1.3.3 Nasal inhalers

1.3.4 Nebulisers

1.4 United States Market Size Sales (Value) and Revenue (Volume) of Inhalers (2011-2021)

1.4.1 United States Inhalers Sales and Growth Rate (2011-2021)

1.4.2 United States Inhalers Revenue and Growth Rate (2011-2021)

2 United States Inhalers Competition by Manufacturers

2.1 United States Inhalers Sales and Market Share of Key Manufacturers (2015 and 2016)

2.2 United States Inhalers Revenue and Share by Manufactures (2015 and 2016)

2.3 United States Inhalers Average Price by Manufactures (2015 and 2016)

2.4 Inhalers Market Competitive Situation and Trends

2.4.1 Inhalers Market Concentration Rate

2.4.2 Inhalers Market Share of Top 3 and Top 5 Manufacturers

2.4.3 Mergers & Acquisitions, Expansion

3 United States Inhalers Sales (Volume) and Revenue (Value) by Type (2011-2016)

3.1 United States Inhalers Sales and Market Share by Type (2011-2016)

3.2 United States Inhalers Revenue and Market Share by Type (2011-2016)

3.3 United States Inhalers Price by Type (2011-2016)

3.4 United States Inhalers Sales Growth Rate by Type (2011-2016)

4 United States Inhalers Sales (Volume) by Application (2011-2016)

4.1 United States Inhalers Sales and Market Share by Application (2011-2016)

4.2 United States Inhalers Sales Growth Rate by Application (2011-2016)

4.3 Market Drivers and Opportunities

5 United States Inhalers Manufacturers Profiles/Analysis

5.1 GlaxoSmithKline

5.1.1 Company Basic Information, Manufacturing Base and Competitors

5.1.2 Inhalers Product Type, Application and Specification

5.1.2.1 Type I

5.1.2.2 Type II

5.1.3 GlaxoSmithKline Inhalers Sales, Revenue, Price and Gross Margin (2011-2016)

5.1.4 Main Business/Business Overview

5.2 Merck

5.2.2 Inhalers Product Type, Application and Specification

5.2.2.1 Type I

5.2.2.2 Type II

5.2.3 Merck Inhalers Sales, Revenue, Price and Gross Margin (2011-2016)

5.2.4 Main Business/Business Overview

5.3 AstraZeneca

5.3.2 Inhalers Product Type, Application and Specification

5.3.2.1 Type I

5.3.2.2 Type II

5.3.3 AstraZeneca Inhalers Sales, Revenue, Price and Gross Margin (2011-2016)

5.3.4 Main Business/Business Overview

5.4 Boehringer-Ingelheim

5.4.2 Inhalers Product Type, Application and Specification

5.4.2.1 Type I

5.4.2.2 Type II

5.4.3 Boehringer-Ingelheim Inhalers Sales, Revenue, Price and Gross Margin (2011-2016)

5.4.4 Main Business/Business Overview

5.5 3M

5.5.2 Inhalers Product Type, Application and Specification

5.5.2.1 Type I

5.5.2.2 Type II

5.5.3 3M Inhalers Sales, Revenue, Price and Gross Margin (2011-2016)

5.5.4 Main Business/Business Overview

5.6 Teva

5.6.2 Inhalers Product Type, Application and Specification

5.6.2.1 Type I

5.6.2.2 Type II

5.6.3 Teva Inhalers Sales, Revenue, Price and Gross Margin (2011-2016)

5.6.4 Main Business/Business Overview

5.7 Sunovion Pharmaceuticals

5.7.2 Inhalers Product Type, Application and Specification

5.7.2.1 Type I

5.7.2.2 Type II

5.7.3 Sunovion Pharmaceuticals Inhalers Sales, Revenue, Price and Gross Margin (2011-2016)

5.7.4 Main Business/Business Overview

5.8 Aristopharma Ltd.

5.8.2 Inhalers Product Type, Application and Specification

5.8.2.1 Type I

5.8.2.2 Type II

5.8.3 Aristopharma Ltd. Inhalers Sales, Revenue, Price and Gross Margin (2011-2016)

5.8.4 Main Business/Business Overview

5.9 Novartis

5.9.2 Inhalers Product Type, Application and Specification

5.9.2.1 Type I

5.9.2.2 Type II

5.9.3 Novartis Inhalers Sales, Revenue, Price and Gross Margin (2011-2016)

5.9.4 Main Business/Business Overview

5.10 Vectura Group

5.10.2 Inhalers Product Type, Application and Specification

5.10.2.1 Type I

5.10.2.2 Type II

5.10.3 Vectura Group Inhalers Sales, Revenue, Price and Gross Margin (2011-2016)

5.10.4 Main Business/Business Overview

5.11 MannKind Corporation

5.12 Respirices,Inc.

5.13 Orion Pharm

5.14 Hovione

6 Inhalers Manufacturing Cost Analysis

6.1 Inhalers Key Raw Materials Analysis

6.1.1 Key Raw Materials

6.1.2 Price Trend of Key Raw Materials

6.1.3 Key Suppliers of Raw Materials

6.1.4 Market Concentration Rate of Raw Materials

6.2 Proportion of Manufacturing Cost Structure

6.2.1 Raw Materials

6.2.2 Labor Cost

6.2.3 Manufacturing Expenses

6.3 Manufacturing Process Analysis of Inhalers

7 Industrial Chain, Sourcing Strategy and Downstream Buyers

7.1 Inhalers Industrial Chain Analysis

7.2 Upstream Raw Materials Sourcing

7.3 Raw Materials Sources of Inhalers Major Manufacturers in 2015

7.4 Downstream Buyers

8 Marketing Strategy Analysis, Distributors/Traders

8.1 Marketing Channel

8.1.1 Direct Marketing

8.1.2 Indirect Marketing

8.1.3 Marketing Channel Development Trend

8.2 Market Positioning

8.2.1 Pricing Strategy

8.2.2 Brand Strategy

8.2.3 Target Client

8.3 Distributors/Traders List

9 Market Effect Factors Analysis

9.1 Technology Progress/Risk

9.1.1 Substitutes Threat

9.1.2 Technology Progress in Related Industry

9.2 Consumer Needs/Customer Preference Change

9.3 Economic/Political Environmental Change

10 United States Inhalers Market Forecast (2016-2021)

10.1 United States Inhalers Sales, Revenue Forecast (2016-2021)

10.2 United States Inhalers Sales Forecast by Type (2016-2021)

10.3 United States Inhalers Sales Forecast by Application (2016-2021)

10.4 Inhalers Price Forecast (2016-2021)

11 Research Findings and Conclusion

12 Appendix

Author List

Disclosure Section

Research Methodology

Data Source

Disclaimer

Figure Picture of Inhalers

Table Classification of Inhalers

Figure United States Sales Market Share of Inhalers by Type in 2015

Figure Reliever inhalers Picture

Figure Preventer inhalers Picture

Figure Long-acting bronchodilator inhalers Picture

Table Application of Inhalers

Figure United States Sales Market Share of Inhalers by Application in 2015

Figure Metered dose inhalers (MDIs) Examples

Figure Dry powder (DPI) Examples

Figure Nasal inhalers Examples

Figure Nebulisers Examples

Figure United States Inhalers Sales and Growth Rate (2011-2021)

Figure United States Inhalers Revenue and Growth Rate (2011-2021)

Table United States Inhalers Sales of Key Manufacturers (2015 and 2016)

Table United States Inhalers Sales Share by Manufacturers (2015 and 2016)

Figure 2015 Inhalers Sales Share by Manufacturers

Figure 2016 Inhalers Sales Share by Manufacturers

Table United States Inhalers Revenue by Manufacturers (2015 and 2016)

Table United States Inhalers Revenue Share by Manufacturers (2015 and 2016)

Table 2015 United States Inhalers Revenue Share by Manufacturers

Table 2016 United States Inhalers Revenue Share by Manufacturers

Table United States Market Inhalers Average Price of Key Manufacturers (2015 and 2016)

Figure United States Market Inhalers Average Price of Key Manufacturers in 2015

Figure Inhalers Market Share of Top 3 Manufacturers

Figure Inhalers Market Share of Top 5 Manufacturers

Table United States Inhalers Sales by Type (2011-2016)

Table United States Inhalers Sales Share by Type (2011-2016)

Figure United States Inhalers Sales Market Share by Type in 2015

Table United States Inhalers Revenue and Market Share by Type (2011-2016)

Table United States Inhalers Revenue Share by Type (2011-2016)

Figure Revenue Market Share of Inhalers by Type (2011-2016)

Table United States Inhalers Price by Type (2011-2016)

Figure United States Inhalers Sales Growth Rate by Type (2011-2016)

Table United States Inhalers Sales by Application (2011-2016)

Table United States Inhalers Sales Market Share by Application (2011-2016)

Figure United States Inhalers Sales Market Share by Application in 2015

Table United States Inhalers Sales Growth Rate by Application (2011-2016)

Figure United States Inhalers Sales Growth Rate by Application (2011-2016)

Table GlaxoSmithKline Basic Information List

Table GlaxoSmithKline Inhalers Sales, Revenue, Price and Gross Margin (2011-2016)

Figure GlaxoSmithKline Inhalers Sales Market Share (2011-2016)

Table Merck Basic Information List

Table Merck Inhalers Sales, Revenue, Price and Gross Margin (2011-2016)

Table Merck Inhalers Sales Market Share (2011-2016)

Table AstraZeneca Basic Information List

Table AstraZeneca Inhalers Sales, Revenue, Price and Gross Margin (2011-2016)

Table AstraZeneca Inhalers Sales Market Share (2011-2016)

Table Boehringer-Ingelheim Basic Information List

Table Boehringer-Ingelheim Inhalers Sales, Revenue, Price and Gross Margin (2011-2016)

Table Boehringer-Ingelheim Inhalers Sales Market Share (2011-2016)

Table 3M Basic Information List

Table 3M Inhalers Sales, Revenue, Price and Gross Margin (2011-2016)

Table 3M Inhalers Sales Market Share (2011-2016)

Table Teva Basic Information List

Table Teva Inhalers Sales, Revenue, Price and Gross Margin (2011-2016)

Table Teva Inhalers Sales Market Share (2011-2016)

Table Sunovion Pharmaceuticals Basic Information List

Table Sunovion Pharmaceuticals Inhalers Sales, Revenue, Price and Gross Margin (2011-2016)

Table Sunovion Pharmaceuticals Inhalers Sales Market Share (2011-2016)

Table Aristopharma Ltd. Basic Information List

Table Aristopharma Ltd. Inhalers Sales, Revenue, Price and Gross Margin (2011-2016)

Table Aristopharma Ltd. Inhalers Sales Market Share (2011-2016)

Table Novartis Basic Information List

Table Novartis Inhalers Sales, Revenue, Price and Gross Margin (2011-2016)

Table Novartis Inhalers Sales Market Share (2011-2016)

Table Vectura Group Basic Information List

Table Vectura Group Inhalers Sales, Revenue, Price and Gross Margin (2011-2016)

Table Vectura Group Inhalers Sales Market Share (2011-2016)

Table MannKind Corporation Basic Information List

Table MannKind Corporation Inhalers Sales, Revenue, Price and Gross Margin (2011-2016)

Table MannKind Corporation Inhalers Sales Market Share (2011-2016)

Table Respirices,Inc. Basic Information List

Table Respirices,Inc. Inhalers Sales, Revenue, Price and Gross Margin (2011-2016)

Table Respirices,Inc. Inhalers Sales Market Share (2011-2016)

Table Orion Pharm Basic Information List

Table Orion Pharm Inhalers Sales, Revenue, Price and Gross Margin (2011-2016)

Table Orion Pharm Inhalers Sales Market Share (2011-2016)

Table Hovione Basic Information List

Table Hovione Inhalers Sales, Revenue, Price and Gross Margin (2011-2016)

Table Hovione Inhalers Sales Market Share (2011-2016)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Inhalers

Figure Manufacturing Process Analysis of Inhalers

Figure Inhalers Industrial Chain Analysis

Table Raw Materials Sources of Inhalers Major Manufacturers in 2015

Table Major Buyers of Inhalers

Table Distributors/Traders List

Figure United States Inhalers Production and Growth Rate Forecast (2016-2021)

Figure United States Inhalers Revenue and Growth Rate Forecast (2016-2021)

Table United States Inhalers Production Forecast by Type (2016-2021)

Table United States Inhalers Consumption Forecast by Application (2016-2021)